Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients

Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients

Coronavirus 2 (SARS-CoV2) (COVID-19) causes severe acute respiratory syndrome. Severe illness of COVID-19 largely occurs in older people and recent evidence indicates that demented patients have higher risk for COVID-19. Additionally, COVID-19 further enhances the vulnerability of older adults with...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Fernando Bartolomé, Luigi Rosa, Piera Valenti, Francisco Lopera, Jesús Hernández-Gallego, José Luis Cantero, Gorka Orive, Eva Carro
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2022-04-01
Cyfres:Frontiers in Immunology
Pynciau:
Alzheimer’s disease
dementia
COVID-19
SARS-CoV2
lactoferrin
saliva
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fimmu.2022.878201/full

Rhyngrwyd

https://www.frontiersin.org/articles/10.3389/fimmu.2022.878201/full

Eitemau Tebyg